Given that APOBEC3B expression is upregulated in breast tumours, and that its upregulation is associated with APOBEC-associated mutational signatures [3–5], it has been suggested that APOBEC3B may be an endogenous source of mutations in cancers, especially breast cancer. Here, APOBEC3B is linked to breast carcinoma.